Form 4 holding
President and CEO, Director
TFF Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 842,095
- Estimated value
- $329,764
- Report date
- 03 Jul 2024
- Price
- $0.3916
- Ownership
- Direct
Harlan F. Weisman - President and CEO, Director at TFF Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- TFFP
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Harlan F. Weisman since 15 Aug 2025
Reported holdings for Harlan F. Weisman in TFF Pharmaceuticals, Inc.
Form 4 holding
President and CEO, Director
TFF Pharmaceuticals, Inc.
- Security class
- Restricted stock units
- Shares / value
- 44,967
- Estimated value
- $17,609
- Report date
- 18 Apr 2024
- Price
- $0.3916
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
Form 4 holding
President and CEO, Director
TFF Pharmaceuticals, Inc.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 27,480
- Estimated value
- Report date
- 03 Jul 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Harlan F. Weisman in TFF Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.